In this study, we found that HCC cells stayed in G1 phase increased after inotodiol treatment by flow cytometry assay, and western blot experiments found that inotodiol decreased CDK2, CDK4, CDK6, Cyclin D protein expression. Here, CDK2 is linked to hepatocellular carcinoma.